In-silico reverse docking and in-vitro studies identified curcumin, 18α-glycyrrhetinic acid, rosmarinic acid, and quercetin as inhibitors of α-glucosidase and pancreatic α …
Introduction Several therapeutic targets have been identified for the management of type 2
diabetes (T2D), including the inhibition of α-amylase and α-glucosidase. The present study …
diabetes (T2D), including the inhibition of α-amylase and α-glucosidase. The present study …
Cytotoxicity of curcumin-loaded magnetic nanoparticles against normal and cancer cells as a breast cancer drug delivery system
AMG Alnooj, M Ghobadi, M Mousavi-Khattat… - …, 2022 - eaapublishing.org
Recently, therapeutic applications of modified magnetic nanoparticles have attracted the
attention of many researchers. The reason is the ability to develop nano drugs as cancer …
attention of many researchers. The reason is the ability to develop nano drugs as cancer …
Naringin may alleviate doxorubicin cytotoxic effects in C2C12 myoblast cells
EP Septisetyani, PW Prasetyaningrum… - IOP Conference Series …, 2021 - iopscience.iop.org
Doxorubicin is one of the first line chemotherapeutic agents used to treat different types of
cancer. However, despite its efficacy, doxorubicin can be toxic to muscle tissue and worsen …
cancer. However, despite its efficacy, doxorubicin can be toxic to muscle tissue and worsen …
In Silico Docking and ADMET Studies on Clinical Targets for Type 2 Diabetes Correlated to In Vitro Inhibition of α-Glucosidase and Pancreatic α-Amylase by Curcumin …
KS Tshiyoyo - 2022 - search.proquest.com
Type 2 diabetes mellitus (T2DM) is a chronic disease characterised by prolonged
hyperglycaemia due to the inability of the liver, muscle, and fat cells to absorb glucose …
hyperglycaemia due to the inability of the liver, muscle, and fat cells to absorb glucose …